Literature DB >> 17239033

Molecular genetics of bipolar disorder and depression.

Tadafumi Kato1.   

Abstract

In this review, all papers relevant to the molecular genetics of bipolar disorder published from 2004 to the present (mid 2006) are reviewed, and major results on depression are summarized. Several candidate genes for schizophrenia may also be associated with bipolar disorder: G72, DISC1, NRG1, RGS4, NCAM1, DAO, GRM3, GRM4, GRIN2B, MLC1, SYNGR1, and SLC12A6. Of these, association with G72 may be most robust. However, G72 haplotypes and polymorphisms associated with bipolar disorder are not consistent with each other. The positional candidate approach showed an association between bipolar disorder and TRPM2 (21q22.3), GPR50 (Xq28), Citron (12q24), CHMP1.5 (18p11.2), GCHI (14q22-24), MLC1 (22q13), GABRA5 (15q11-q13), BCR (22q11), CUX2, FLJ32356 (12q23-q24), and NAPG (18p11). Studies that focused on mood disorder comorbid with somatic symptoms, suggested roles for the mitochondrial DNA (mtDNA) 3644 mutation and the POLG mutation. From gene expression analysis, PDLIM5, somatostatin, and the mtDNA 3243 mutation were found to be related to bipolar disorder. Whereas most previous positive findings were not supported by subsequent studies, DRD1 and IMPA2 have been implicated in follow-up studies. Several candidate genes in the circadian rhythm pathway, BmaL1, TIMELESS, and PERIOD3, are reported to be associated with bipolar disorder. Linkage studies show many new linkage loci. In depression, the previously reported positive finding of a gene-environmental interaction between HTTLPR (insertion/deletion polymorphism in the promoter of a serotonin transporter) and stress was not replicated. Although the role of the TPH2 mutation in depression had drawn attention previously, this has not been replicated either. Pharmacogenetic studies show a relationship between antidepressant response and HTR2A or FKBP5. New technologies for comprehensive genomic analysis have already been applied. HTTLPR and BDNF promoter polymorphisms are now found to be more complex than previously thought, and previous papers on these polymorphisms should be treated with caution. Finally, this report addresses some possible causes for the lack of replication in this field.

Entities:  

Mesh:

Year:  2007        PMID: 17239033     DOI: 10.1111/j.1440-1819.2007.01604.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  74 in total

1.  The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.

Authors:  Dhaval Nanavati; Daniel R Austin; Lisa A Catapano; David A Luckenbaugh; Ayse Dosemeci; Husseini K Manji; Guang Chen; Sanford P Markey
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

2.  Explaining the covariance between attention-deficit hyperactivity disorder symptoms and depressive symptoms: the role of hedonic responsivity.

Authors:  Michael C Meinzer; Jeremy W Pettit; Adam M Leventhal; Ryan M Hill
Journal:  J Clin Psychol       Date:  2012-07-06

Review 3.  Developmental plasticity and evolution--quo vadis?

Authors:  A P Moczek
Journal:  Heredity (Edinb)       Date:  2015-03-18       Impact factor: 3.821

Review 4.  Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers.

Authors:  H Le-Niculescu; M J McFarland; S Mamidipalli; C A Ogden; R Kuczenski; S M Kurian; D R Salomon; Ming T Tsuang; J I Nurnberger; A B Niculescu
Journal:  Neurosci Biobehav Rev       Date:  2007-06-03       Impact factor: 8.989

5.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

Review 6.  Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder.

Authors:  Elena Ivleva; Gunvant Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2008-05-30       Impact factor: 9.306

7.  A role for PKC in mediating stress-induced prefrontal cortical structural plasticity and cognitive function.

Authors:  Guang Chen; Ioline D Henter; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-14       Impact factor: 11.205

8.  Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects.

Authors:  Neil Patel; Amanda Crider; Chirayu D Pandya; Anthony O Ahmed; Anilkumar Pillai
Journal:  Mol Neurobiol       Date:  2015-04-26       Impact factor: 5.590

9.  Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Authors:  Dara M Cannon; Jacqueline M Klaver; Summer A Peck; Denise Rallis-Voak; Kristine Erickson; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

10.  A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B.

Authors:  Lorna M Houlihan; Andrea Christoforou; Margaret I Arbuckle; Helen S Torrance; Susan M Anderson; Walter J Muir; David J Porteous; Douglas H Blackwood; Kathryn L Evans
Journal:  J Psychiatr Res       Date:  2009-06-17       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.